Mukka Proteins approves ₹47 crore convertible warrant issue
- Mukka Proteins raised ₹47 crore via preferential allotment of 2 crore convertible warrants at ₹23.50 each
- Investors paid an upfront subscription of ₹5.88 per warrant, covering 25% of the issue price
- Fifteen non-promoter investors participated, with Vishal Maniar receiving the largest allotment of 25 lakh warrants
- Warrants are convertible into one equity share each within 18 months upon payment of the balance amount
*this image is generated using AI for illustrative purposes only.
Mukka Proteins approved the preferential allotment of 2 crore convertible warrants at ₹23.50 each, raising ₹47 crore from 15 non-promoter investors. The Board passed the resolution by circulation on September 9, 2026, following shareholder approval via postal ballot on July 12, 2026.
The company received an upfront subscription amount of ₹5.88 per warrant, representing 25% of the issue price, in compliance with Regulation 169 of the SEBI ICDR Regulations. Each warrant entitles the holder to subscribe to one fully paid-up equity share of face value ₹1 upon payment of the remaining 75% balance within 18 months from the date of allotment.
Allotment Details
The issuance targets identified persons in the Non-Promoter category. The largest single allotment went to Mr. Vishal Maniar, who received 25 lakh warrants. Other significant investors include Mr. Hiren Hiralal Shiyal, Mr. B A Abdul Nasir, Mr. Soofikhan Kalander Asif, and Mr. B H Rizwan, each allotted 22.5 lakh warrants.
| Investor Name | Category | Warrants Allotted |
|---|---|---|
| Mr. Vishal Maniar | Non-Promoter | 25,00,000 |
| Mr. Hiren Hiralal Shiyal | Non-Promoter | 22,50,000 |
| Mr. B A Abdul Nasir | Non-Promoter | 22,50,000 |
| Mr. Soofikhan Kalander Asif | Non-Promoter | 22,50,000 |
| Mr. B H Rizwan | Non-Promoter | 22,50,000 |
| Mr. Irfan Chapra | Non-Promoter | 21,75,000 |
| Ms. Reshma Chapra | Non-Promoter | 21,75,000 |
| Ms. Payal Maniar | Non-Promoter | 12,00,000 |
| Mr. Jasbir Singh Batra | Non-Promoter | 5,00,000 |
| Mr. Ranjit Singh Batra | Non-Promoter | 5,00,000 |
| Mr. Gurminder Kaur | Non-Promoter | 4,00,000 |
| Jasbir Singh And Sons HUF | Non-Promoter | 4,00,000 |
| Mr. Sarabdeep Kaur Darshan Singh | Non-Promoter | 4,00,000 |
| Ranjit Singh and Sons HUF | Non-Promoter | 4,00,000 |
| Multiplex Capital Limited | Non-Promoter | 3,50,000 |
Terms and Conditions
The convertible warrants and the equity shares arising from their conversion are subject to lock-in requirements under Chapter V of the SEBI ICDR Regulations. If a warrant holder fails to exercise the conversion option within the stipulated 18-month period, the warrants will lapse, and the amount already paid will be forfeited as per the terms of issue.
Historical Stock Returns for Mukka Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.81% | +14.34% | +31.14% | +42.06% | +10.59% | 0.0% |
How will the potential dilution of up to 2 crore equity shares impact Mukka Proteins' earnings per share (EPS) and existing promoter ownership stakes upon full conversion?
What specific strategic initiatives or capital expenditures is Mukka Proteins planning to fund with the ₹47 crore raised through this preferential allotment?
Given the 18-month conversion window, what market conditions or company performance metrics might influence investors' decisions to exercise their warrants before they lapse?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
